Kurihara A, Ojima F, Tsurufuji S
J Pharmacobiodyn. 1984 Oct;7(10):747-54. doi: 10.1248/bpb1978.7.747.
For the determination of leukocyte chemotaxis in the Boyden chamber toward zymosan-activated serum, a modification of the 51Cr-labeling method originally introduced by Gallin et al. was made using a polycarbonate filter at the top of a double filter system. By application of this method, it was demonstrated that an anti-inflammatory steroid, dexamethasone at relatively low doses, directly inhibited chemotactic movement of leukocytes after the pretreatment of the cells with dexamethasone for several hours. This inhibitory effect was proved to be a common property of glucocorticoids. The leukocyte-inhibitory effect manifested within the cell body and the release of any extracellular factors mediating the inhibitory effect of the corticoid into the medium was not demonstrated. The present data suggests that the inhibitory effect of dexamethasone on leukocyte infiltration observed in vivo is attributed to the direct inhibitory effect of dexamethasone on the motility of leukocytes.
为了在博伊登小室中测定白细胞对酵母聚糖激活血清的趋化性,对加林等人最初引入的51Cr标记方法进行了改进,在双滤器系统顶部使用聚碳酸酯滤器。通过应用该方法,证明了一种抗炎类固醇,相对低剂量的地塞米松,在用其对细胞预处理数小时后,可直接抑制白细胞的趋化运动。这种抑制作用被证明是糖皮质激素的共同特性。白细胞抑制作用在细胞体内表现出来,并且未证明有任何介导皮质类固醇抑制作用的细胞外因子释放到培养基中。目前的数据表明,体内观察到的地塞米松对白细胞浸润的抑制作用归因于地塞米松对白细胞运动性的直接抑制作用。